JUAN DIEGO
MEDIAVILLA GARCÍA
PROFESOR ASOCIADO CIENCIAS SALUD
![Foto de José Luis](/img/nophoto.png)
José Luis
Díaz Díaz
Publicacións nas que colabora con José Luis Díaz Díaz (5)
2024
-
Characteristics of Coronary Atherosclerosis Related to Plaque Burden Regression During Treatment With Alirocumab: The ARCHITECT Study
Circulation. Cardiovascular imaging, Vol. 17, Núm. 1, pp. e016206
2023
-
Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study
Circulation, Vol. 147, Núm. 19, pp. 1436-1443
2022
-
A resilient type of familial hypercholesterolaemia: case-control follow-up of genetically characterized older patients in the SAFEHEART cohort
European Journal of Preventive Cardiology, Vol. 29, Núm. 5, pp. 795-801
2021
-
The Added Value of Coronary Calcium Score in Predicting Cardiovascular Events in Familial Hypercholesterolemia
JACC: Cardiovascular Imaging, Vol. 14, Núm. 12, pp. 2414-2424
2016
-
Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study
Journal of the American Heart Association, Vol. 5, Núm. 9